The National Advisory Council of the Thalidomide Trust is a user-based body that represents currently 443 beneficiaries of the Thalidomide Trust and assists the management with its objectives one of which is to ensure a beneficiary-centred approach in all Trust activities - with an emphasis on equity, empowerment and support.